Gossamer Bio ROE Ratio 2011-2026 | GOSS

Annual ROE Ratio Gossamer Bio

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-286.47	-1899.3	-192.65	-75.89	-51.15	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-51.15	-1899.3	-501.09

Quarterly ROE Ratio Gossamer Bio

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
670.89	555.42	532.8	-153.42	-191.66	-173.0	-165.72	202.2	96.86	29.75	305.11	46.08	10.6	80.47	-289.67	-83.78	-101.8	-84.35	-78.09	-55.74	-71.26	-66.99	-58.76	-51.15	-3.33	51.58	91.47	122.4	90.09	48.94	21.69	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
670.89	-289.67	42.83

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	-15.14	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
ARCA biopharma ABIO	-21.9	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	156.54	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-14.36	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-270.67	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-36.89	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	160.57	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	-34.6	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	3.1	-	-	-	Russia
Фармсинтез LIFE	-51.75	-	-	-	Russia
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Alector ALEC	-466.34	$ 2.19	-9.77 %	$ 226 M	USA
Entera Bio Ltd. ENTX	-149.78	$ 1.38	-0.72 %	$ 63.3 M	Israel
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	-115.61	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	-76.97	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	473.41	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	-51.87	-	4.14 %	$ 49.1 M	USA
Evogene Ltd. EVGN	-41.09	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	-40.09	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	-10.71	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	-55.54	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	-22.46	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	-50.55	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	-20.19	$ 0.83	5.37 %	$ 4.53 M	China
Apellis Pharmaceuticals APLS	6.05	$ 20.67	-1.38 %	$ 2.61 B	USA
Aptose Biosciences APTO	559.76	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Cleveland BioLabs, Inc. CBLI	-119.12	-	-7.31 %	$ 49 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA